… Inhaled corticosteroids (ICSs) are widely used in the treatment of patients with chronic …
The use of ICSs can also be associated with the risk of bone fractures, diabetes mellitus and …

… , very low doses of inhaled corticosteroids may be associated with a reduction in the risk of
acute … In conclusion, the results presented here suggest that inhaled corticosteroids may be …

… using inhaled corticosteroids are at increased risk for fracture. This increased risk is more
likely to be the result of the underlying illness rather than the usage of inhaled corticosteroids. …

There is a considerable amount of evidence that supports the possibility of an increased risk
of pneumonia associated with prolonged use of inhaled corticosteroids (ICS) in patients …

… -term use of inhaled corticosteroids (ICSs), widely used to treat COPD, increases the risk
of fracture, particularly in women, in view of the postmenopausal risks. We assessed whether …

… of adrenal insufficiency although the absolute risk is small. … risk in people prescribed an
inhaled corticosteroid is largely due to oral corticosteroid exposure, but inhaled corticosteroids …

The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of patients
with chronic obstructive pulmonary disease (COPD) is much debated, since it can result in …

… Inhaled corticosteroids remain the most important therapy for chronic asthma in both adults
and children. As all inhaled corticosteroids … Use of inhaled corticosteroids and the risk of bone …

… Context Recent studies of inhaled corticosteroid (ICS) therapy for managing stable chronic
… Inhaled corticosteroid therapy was not associated with a decreased risk of death at 1-year …

… Use of inhaled corticosteroids resulted in an increased risk of TB (OR = 1.46; 95% CI 1.06
to 2.01). The risk was seen across all doses of ICS usage and a dose–response relationship …